303.6000 -0.75 (-0.25%)
NSE Jun 06, 2025 15:31 PM
Volume: 101.9K
 

303.60
-0.25%
Emkay
Advanced Enzymes' (ADVENZY) Q4FY18 results were in line with our estimate. Revenue stood at Rs1.08bn, up 26% yoy (Emkay Est: Rs1.08bn). US, India, Asia, Europe and Others geographies grew by 36%, 7%, 281%, 27% and 154% yoy, respectively. Revenue growth was driven by Human Nutrition (+36% yoy | 76% of revenue), Industrial Processing (+27% yoy | 5% of Rev.) and Animal Healthcare (5% yoy | 14% of Rev);...
Advanced Enzyme Technologies Ltd. is trading above its 100 day SMA of 299.4
More from Advanced Enzyme T…
All earning calls
Investor presentations from Advanced Enzyme T…
All investor presentations